Free Trial

AdvanSix (NYSE:ASIX) Upgraded by Wall Street Zen to Buy Rating

AdvanSix logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded AdvanSix from a "hold" to a "buy" rating, though the consensus on MarketBeat remains a Hold with an average target price of $25.67.
  • AdvanSix beat expectations for the quarter with EPS of $0.03 versus a -$0.06 estimate and revenue of $359.95M versus $340.85M, while the stock trades near $23.94 with a market cap of $643.27M and a P/E of 13.23.
  • Institutional investors have been active—Aegis and Millennium established large new stakes and firms like Goldman Sachs and AllianceBernstein materially increased positions—leaving institutions owning about 86.39% of the company.
  • Five stocks we like better than AdvanSix.

AdvanSix (NYSE:ASIX - Get Free Report) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued on Saturday.

A number of other research analysts have also recently weighed in on the stock. Weiss Ratings raised shares of AdvanSix from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, March 25th. Loop Capital set a $25.00 price objective on shares of AdvanSix in a report on Thursday, March 12th. Finally, Truist Financial lifted their price objective on shares of AdvanSix from $19.00 to $20.00 and gave the company a "hold" rating in a report on Monday, February 23rd. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, AdvanSix currently has an average rating of "Hold" and a consensus target price of $25.67.

Read Our Latest Report on ASIX

AdvanSix Stock Up 2.6%

ASIX opened at $23.94 on Friday. AdvanSix has a fifty-two week low of $14.10 and a fifty-two week high of $25.94. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.52 and a current ratio of 1.13. The company has a fifty day moving average of $20.45 and a two-hundred day moving average of $18.53. The stock has a market capitalization of $643.27 million, a price-to-earnings ratio of 13.23 and a beta of 1.43.

AdvanSix (NYSE:ASIX - Get Free Report) last released its quarterly earnings data on Friday, February 20th. The company reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of ($0.06) by $0.09. AdvanSix had a net margin of 3.24% and a return on equity of 6.97%. The company had revenue of $359.95 million during the quarter, compared to analysts' expectations of $340.85 million. On average, research analysts expect that AdvanSix will post 4 earnings per share for the current year.

Institutional Trading of AdvanSix

Several large investors have recently bought and sold shares of ASIX. Aegis Financial Corp purchased a new stake in AdvanSix during the 4th quarter valued at about $20,927,000. Millennium Management LLC purchased a new stake in AdvanSix during the 4th quarter valued at about $11,479,000. Alliancebernstein L.P. grew its stake in AdvanSix by 55.3% during the 3rd quarter. Alliancebernstein L.P. now owns 948,491 shares of the company's stock valued at $18,382,000 after acquiring an additional 337,908 shares in the last quarter. Invenomic Capital Management LP purchased a new stake in AdvanSix during the 3rd quarter valued at about $6,054,000. Finally, Goldman Sachs Group Inc. grew its stake in AdvanSix by 149.3% during the 4th quarter. Goldman Sachs Group Inc. now owns 378,610 shares of the company's stock valued at $6,550,000 after acquiring an additional 226,756 shares in the last quarter. Hedge funds and other institutional investors own 86.39% of the company's stock.

About AdvanSix

(Get Free Report)

AdvanSix, Inc NYSE: ASIX is an integrated chemical manufacturer specializing in the production of nylon 6 intermediates and related co‐products. Established as a publicly traded spin‐off from Honeywell Specialty Chemicals in June 2016, the company is headquartered in Parsippany, New Jersey.

The company’s principal product is caprolactam, the key building block for nylon 6 resin, used in fibers and engineering plastics across industries. In addition to caprolactam and nylon 6 resin, AdvanSix produces ammonium sulfate fertilizer and industrial chemicals such as phenol and acetone.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AdvanSix Right Now?

Before you consider AdvanSix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.

While AdvanSix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines